KC CO., LTD.

029460KOSPIMedical, precision and optical instruments

KC CO., LTD. (029460, KOSPI) reported KRW 797bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
202372766611,062865Consolidated
202473828511,047858Consolidated
202579746501,153969Consolidated

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
20239.1%8.5%81.4%7.1%
20243.8%7%81.9%6%
20255.8%6.3%84%5.2%

Revenue moved 9.7% between 2023 and 2025.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 426bn
Close priceKRW 38,700
Listed shares11,020,535
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)235
Women24 (10.2%)
Average tenure6.3 years
Annual pay, menKRW 82,971,365
Annual pay, womenKRW 70,641,333
Pay ratio, women to men85.1%

Other companies in Medical, precision and optical instruments

102 listed companies file under this classification. Showing 12.

See the whole Medical, precision and optical instruments list →